Prices delayed by at least 15 minutes | Print
N4 Pharma PLC (N4P)
ORD 0.4POpen
0.375p
Previous close
0.375p
Trade high
0.40p
Volume
336,366
Year high
0.80p
Year low
0.35p
Dividend yield
–
Market capitalisation
£3.12 mn
P/E ratio
–
ISIN
GB00BYW8QM32
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
N4 Pharma PLC is the holding company for N4 UK. N4 UK is a specialist pharmaceutical company engaged in the development of nanoparticle silica delivery systems to improve the cellular delivery and potency of cancer treatments and vaccines.The company operated in one business segment, that of the development and commercialisation of medicines via its delivery system called Nuvec and its liptide platform called ECP105.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 04/07/2025 | 11:12:05 | 0.375 | 216,000 | 810.00 |
| 04/07/2025 | 10:14:31 | 0.35 | 19,366 | 67.78 |
| 04/07/2025 | 09:45:20 | 0.4 | 1,000 | 4.00 |
| 04/07/2025 | 09:07:09 | 0.35 | 100,000 | 350.00 |
| 03/07/2025 | 03:51:20 | 0.35 | 100,000 | 350.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.